Phase 2 Multiple Sclerosis Trial, Not Yet Recruiting NCT07310914 Sponsor: Danish Multiple Sclerosis Hospitals Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Phase 2 Multiple Sclerosis Trial, Not Yet Recruiting

NCT07310914
Not Yet Recruiting Phase 2

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been formally diagnosed with multiple sclerosis (MS) — either the relapsing-remitting or progressive type — according to established diagnostic guidelines called the McDonald criteria.
  • People whose level of physical disability falls within a specific mid-range on a standard MS disability scale, meaning they retain at least some ability to walk (at least 20 metres on their own, with or without a walking aid such as a cane or walker).
  • People who are willing to travel to the local study location for assessment sessions.
  • People who have access to an internet platform (confirm with trial site regarding specific requirements).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have other health conditions that would prevent them from taking part in the study.
  • People who have experienced a documented MS relapse or received steroid (corticosteroid) treatment within the past three months.
  • People with significant cognitive difficulties that would prevent them from following simple instructions or from giving informed consent to participate.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 29 July 2026

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 2
Sponsor
Danish Multiple Sclerosis Hospitals
Registry
ClinicalTrials.gov
Start date
1 February 2026
Est. completion
31 December 2026

Where this trial is recruiting

🇩🇰 Denmark 🇮🇪 Ireland 🇮🇱 Israel 🇮🇹 Italy

Primary endpoints

30 second sit to stand test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov